All Clinical Trials

A listing of 23116 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

Featured Offer

Lose 20% of Body Weight With GLP-1's

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).

Get $50 off your first order using promo code: policy-lab-50

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Chronic Cough Study

Recruiting

Are you tired of living with chronic cough? The ASPIRE Study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough. You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you.

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Allergic Asthma

Learn More

Featured Trial

Buy Retatrutide Online Through Celia

Recruiting

Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.

Conditions:

Healthy

Learn More

Featured Trial

COVID-19 Vaccine Clinical Trial (Compensation Provided)

Recruiting

Healthy adults ages 50-64 may qualify. You may be eligible if you haven’t received a COVID-19 vaccine and haven’t had COVID-19 in the last 90 days.

Qualified participants may receive compensation for time and travel.

Conditions:

Healthy

Vaccine

COVID19

COVID-19

COVID-19 Vaccine

Learn More

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

NCT05219617

Recruiting

The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in pediatric and adult subjects (age 4-55 years) diagnosed with Lennox Gastaut Syndrome (LGS).

Gender:

ALL

Ages:

Between 4 years and 55 years

Trial Updated:

07/21/2025

Locations: Stanford University Hospital, Palo Alto, California +70 locations

Stanford University Hospital, Palo Alto, California

University of Florida Health Science Center, Jacksonville, Florida

AdventHealth, Orlando, Florida

Pediatric Epilepsy and Neurology Specialists, Tampa, Florida

University of South Florida, Tampa, Florida

Axcess Medical Research, Wellington, Florida

Consultants in Epilepsy and Neurology PLLC, Boise, Idaho

Bluegrass Epilepsy Research, LLC, Lexington, Kentucky

University Medical Center New Orleans, New Orleans, Louisiana

Johns Hopkins Hospital, Baltimore, Maryland

Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland

Mayo Clinic, Rochester, Minnesota

University of Missouri School of Medicine, Columbia, Missouri

Northeast Regional Epilepsy Group, Hackensack, New Jersey

St. Peters Hospital, New Brunswick, New Jersey

Montefiore, Bronx, New York

Duke University Clinical Research at Pickett Road, Durham, North Carolina

Wake Forest University - School of Medicine, Winston-Salem, North Carolina

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Austin Epilepsy Care Center - Clinic/Outpatient Facility, Austin, Texas

Neurology Consultants of Dallas, PA - Hospital, Dallas, Texas

Virginia Epilepsy and Neurodevelopmental Clinic at WNC, Winchester, Virginia

Hospital de Ninos de La Santisma Trinidad, Córdoba, Cordoba

Resolution Psychopharmacology Research Institute, Mendoza, Not set

Austin Hosptial, Heidelberg, Not set

Alfred Health, Melbourne, Not set

Perth's Children Hospital, Nedlands, Not set

Queensland Children's Hospital, South Brisbane, Not set

Fundacion Hospital Universidad del Norte, Barranquilla, Not set

Fundacion Valle del Lili/Clinic - Outpatient, Cali, Not set

CliniSalud del Sur S.A.S - Centro de Investigación, Envigado, Not set

Hospital Pabloe Tubon Uribe, Medellín, Not set

Institutio Neurologico de Colombia, Medellín, Not set

Universitatsklinikum Erangen, Erlangen, Bayern

Kleinwachau Sächsisches Epilepsiezentrum, Radeberg, Sachsen

Iaso Children's Hospital, Maroúsi, Attiki

Orszagos Mentalis, Ideggyogyaszati es Idegsebezeti Intezet, Budapest, Not set

Semmelweis Egyetem Idegsebeszeti es Neurointervencios Klinika, Budapest, Not set

Tela Viv Sourlasky Medical Center, Tel Aviv Yafo, Tel Aviv

Soroka University Medical Centre, Be'er Sheva, Not set

Hadassah Medical Center, Jerusalem, Not set

Sheba Medical Center, Ramat Gan, Not set

Istituto G Gaslini Ospedale Pediatrico IRCCS - INCIPIT - PIN, Genova, Liguria

ASST Fatebenefratelli Sacco - Ospedale dei Bambini Vittore Buzzi, Milano, Lombardia

Fondazione IRCCS Di Rilievo Nazionale Instituto, Milano, Lombardia

Azienda Ospedaliero Universitaria A Meyer - INCIPIT - PIN, Firenze, Not set

ASST Santi Paolo E Carlo - Azienda Universitaria-Polo Universitaria - San Paolo, Milano, Not set

Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Not set

Kyungpook National University Chilgok Hospital, Daegu, Not set

Samsung Medical Center, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco

Neurociencias Estudios Clinicos S.C., Culiacán, Not set

Clinstile, S.A. de C.V., Mexico City, Not set

Szpital Kliniczny im.H.Swiecickiego Uniwersytetu Medycznego im.K.Marcinkowskiego w Poznaniu-Dluga1/2, Poznan, Wielkopolskie

Centrum Medyczne Plejady, Kraków, Not set

Hospital Garcia de Orta, Almada, Setubal

Centro Hospitalar de Lisboa Norte, EPE, Lisboa, Not set

Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Sao Francisco Xavier, Lisboa, Not set

Centro Hospitalar de Sao Joao, EPE, Porto, Not set

Childrens University Hospital, Belgrade, Not set

University Clinical Center of Serbia - PPDS, Belgrade, Not set

University Clinical Center Kragujevac, Kragujevac, Not set

University Clinical Center Nis, Niš, Not set

Children and Youth Health Care Institute of Vojvodina, Novi Sad, Not set

Hospital Sant Joan de Deu - PIN, Esplugues De Llobregat, Barcelona

Hospital Infantil Universitario Niño Jesus - PIN, Madrid, Not set

Hospital Ruber Internacional (Grupo Quironsalud), Madrid, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Memorial Hospital, Taoyuan, Not set

Conditions: Seizures, Lennox Gastaut Syndrome

Learn More ›

Nicotinamide Riboside Clinical Trial for GWI

NCT05243290

Recruiting

In this multi-site trial, we will use a randomized, double-blind, placebo-controlled study design to test whether 300 mg of Nicotinamide Riboside (NR) can achieve the primary objective of increasing plasma NAD+ levels in participants with Gulf War Illness (GWI).

Gender:

ALL

Ages:

Between 47 years and 70 years

Trial Updated:

07/21/2025

Locations: Nova Southeastern University, Fort Lauderdale, Florida +1 locations

Conditions: Gulf War Illness

Learn More ›

Training Swallowing Initiation During Expiration

NCT05278039

Recruiting

Head and neck cancers have escalated to epidemic levels in the United States, and survivors are suffering from life-long, devastating swallowing disorders with limited therapeutic options. This clinical trial investigates a novel swallowing treatment that trains initiation of swallowing during the expiratory phase of respiration to improve swallowing safety and efficiency.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/21/2025

Locations: Northwestern Memorial Hospital, Chicago, Illinois +1 locations

Conditions: Head and Neck Cancer, Dysphagia, Oropharyngeal Dysphagia, Oropharynx Squamous Cell Carcinoma

Learn More ›

FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea

NCT05364008

Recruiting

The objective of this study is to determine the effect of low caffeine green tea extract containing 45% epigallocatechin gallate (EGCG) on fibroids and subsequent pregnancy and live births in women seeking fertility treatment. The population will consist of 50 women desirous of conceiving, ages ≥18 to ≤40 years (at time of consent), and known to have class 2-6 fibroids, according to the FIGO staging system.

Gender:

FEMALE

Ages:

Between 18 years and 40 years

Trial Updated:

07/21/2025

Locations: Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences, New Haven, Connecticut +3 locations

Conditions: Leiomyoma, Uterine

Learn More ›

Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI

NCT05377177

Recruiting

This is a prospective clinical trial to confirm the effectiveness of bilateral accelerated theta burst stimulation (aTBS) on suicidal ideation (SI), while exploring cortical inhibition measures in this treatment paradigm. In this proposed study, the investigators will evaluate the anti-suicidal effects of bilateral aTBS over the DLPFC compared to accelerated intermittent theta burst stimulation (aiTBS) over the left DLPFC in participants with TRD and SI. Additionally, the investigators aim to id... Read More

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

07/21/2025

Locations: UCSD Interventional Psychiatry, San Diego, California

Conditions: Suicidal Ideation, Treatment-resistant Depression

Learn More ›

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

NCT05384626

Recruiting

Phase 1/2, dose escalation and expansion study designed to evaluate the safety and tolerability of neladalkib (NVL-655), determine the recommended phase 2 dose (RP2D), and evaluate the antitumor activity in patients with advanced ALK- positive (ALK+) NSCLC and other solid tumors. Phase 1 will evaluate the overall safety and tolerability of neladalkib and will determine the RP2D and, if applicable, the maximum tolerated dose (MTD) of neladalkib in patients with advanced ALK+ solid tumors. Phase... Read More

Gender:

ALL

Ages:

12 years and above

Trial Updated:

07/21/2025

Locations: University of California Irvine Medical Center, Orange, California +73 locations

University of California Irvine Medical Center, Orange, California

University of California, Davis Comprehensive Cancer Center, Sacramento, California

Stanford Cancer Institute, Stanford, California

University of Colorado Cancer Center, Aurora, Colorado

Georgetown University Medical Center, Washington, District of Columbia

University of Miami; Sylvester Cancer Center, Miami, Florida

Winship Cancer Institute, Emory University, Atlanta, Georgia

University of Chicago Medical Center, Chicago, Illinois

John Hopkins University, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Henry Ford Cancer Institute, Detroit, Michigan

Washington University School of Medicine Siteman Cancer Center, Saint Louis, Missouri

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Duke University Medical Center, Durham, North Carolina

OSU Brain & Spine Hospital, Columbus, Ohio

University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania

Sarah Cannon, Nashville, Tennessee

MD Anderson Cancer Center, Houston, Texas

Fred Hutchinson Cancer Center, Seattle, Washington

Royal North Shore Hospital, Sydney, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Peter MacCallum Cancer Centre, Melbourne, Victoria

Universitair Ziekenhuis Antwerpen (UZA), Antwerp, Not set

Universitaire Ziekenhuizen Leuven Campus Gastthuisberg, Leuven, Not set

Cross Cancer Institute, Edmonton, Alberta

BC Cancer Center, Vancouver, British Columbia

The Ottawa Hospital Cancer Center, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Centre Leon Berard, Lyon, Not set

Chu De Nantes, Nantes, Not set

Institut Claudius Regaud, Toulouse Cedex, Not set

Institute Gustave Roussy, Villejuif, Not set

Universitatsklinikum Koln - University Hospital Cologne, Cologne, Not set

Universitätsklinikum Frankfurt, Frankfurt, Not set

LungenClinic Grosshansdorf GmbH, Grosshansdorf, Not set

Universkitatsklinikum Heidelberg - University Hospital Heidelberg, Heidelberg, Not set

Azienda Ospedaliera Universitaria Ospedali Riuniti Umberto, Ancona, Not set

IRCCS Istituto Tumori "G. Paolo II", Bari, Not set

Instituto Europeo di Oncologia, Milano, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Instituto Oncologico Veneto, Padova, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Regina Elena Institute for Cancer Research, Rome, Not set

Kanagawa Cancer Center, Kanagawa, Not set

Okayama University Hospital, Okayama, Not set

Kindai University Hospital, Osaka, Not set

Shizuoka Cancer Center, Shizuoka, Not set

National Cancer Center Hospital, Tokyo, Not set

Center Institute Hospital of JFCR, Tokyo, Not set

Wakayama Medical University Hospital, Wakayama, Not set

National Cancer Center, Goyang-si, Gyeonggi-do

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Samsung Medical Center, Seoul, Not set

The Netherlands Cancer Institute, Amsterdam, Not set

University Medical Center Groningen (UMCG), Groningen, Not set

National University Hospital, Singapore, Not set

National Cancer Centre Singapore, Singapore, Not set

Complejo Hospitalario Universitario de A Coruna, A Coruña, Not set

UOMI Cancer Center, Barcelona, Not set

Vall d'Hebron, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Istituto Oncologico Svizzera Italiana, Bellinzona, Not set

Luzerner Kantonsspital, Luzern, Not set

Chung-Shan Medical University Hospital, Taichung City, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Royal Marsden Hospital, Sutton, Surrey

Edinburgh Cancer Centre, Edinburgh, Not set

The Royal Marsden - Chelsea, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor

Learn More ›

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

NCT05415358

Recruiting

The purpose of this study is to examine the association between ctDNA/immune biomarkers and disease progression in patients who, at immunotherapy discontinuation, have completed at least 20 of an anticipated 24 months of immune checkpoint inhibitor monotherapy or immune checkpoint inhibitor combination chemotherapy for mNSCLC.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/21/2025

Locations: Atrium Health Levine Cancer, Charlotte, North Carolina +1 locations

Conditions: Lung Cancer, Nonsmall Cell

Learn More ›

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT05445778

Recruiting

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/21/2025

Locations: Usa Mitchell Cancer Institute /ID# 269661, Mobile, Alabama +239 locations

Usa Mitchell Cancer Institute /ID# 269661, Mobile, Alabama

Honorhealth Virginia G. Piper Cancer Care Network - Biltmore /ID# 269987, Phoenix, Arizona

City of Hope Orange County Lennar Foundation Cancer Center /ID# 269573, Irvine, California

Moores Cancer Center at UC San Diego /ID# 269564, La Jolla, California

University Of California Irvine Medical Center /ID# 269572, Orange, California

Stanford Women'S Cancer Center /ID# 269552, Palo Alto, California

Kaiser Permanente Zion Medical Center /ID# 269537, San Diego, California

Kaiser Permanente - San Diego Medical Center /ID# 269540, San Diego, California

Kaiser Permanente - San Marcos Medical Offices /ID# 269542, San Marcos, California

Olive View-Ucla Medical Center /ID# 269584, Sylmar, California

John Muir Health - Walnut Creek Medical Center /ID# 269575, Walnut Creek, California

Broward General Medical Center /ID# 269577, Fort Lauderdale, Florida

Regional Cancer Center /ID# 269558, Fort Myers, Florida

Baptist Md Anderson Cancer Center - Jacksonville - Palm Avenue /ID# 269560, Jacksonville, Florida

Mount Sinai Medical Center /ID# 269582, Miami, Florida

Sarasota Memorial Hospital /ID# 269526, Sarasota, Florida

Northside Hospital /ID# 269660, Atlanta, Georgia

Rush University Medical Center /ID# 269583, Chicago, Illinois

University of Chicago Medical Center /ID# 269546, Chicago, Illinois

Indiana University Melvin and Bren Simon Comprehensive Cancer Center /ID# 269110, Indianapolis, Indiana

St. Vincent Indianapolis Hospital /ID# 269107, Indianapolis, Indiana

University of Iowa /ID# 269566, Iowa City, Iowa

The University of Kansas Cancer Center - Westwood /ID# 269106, Westwood, Kansas

Baptist Health Lexington /ID# 269568, Lexington, Kentucky

University of Kentucky Chandler Medical Center /ID# 269536, Lexington, Kentucky

Louisiana State University Health Sciences Center - New Orleans /ID# 269559, New Orleans, Louisiana

Ochsner Medical Center - Jefferson Highway /ID# 269530, New Orleans, Louisiana

Maine Medical Center - Scarborough Campus /ID# 269555, Scarborough, Maine

Johns Hopkins Hospital /ID# 269579, Baltimore, Maryland

Sinai Hospital Of Baltimore /ID# 269567, Manchester, Maryland

GBMC Cancer Center /ID# 269561, Towson, Maryland

Tufts Medical Center /ID# 269547, Boston, Massachusetts

Baystate Medical Center /ID# 269544, Springfield, Massachusetts

Corewell Health /ID# 269562, Grand Rapids, Michigan

Minnesota Oncology - Coon Rapids Clinic /ID# 269550, Coon Rapids, Minnesota

Nebraska Methodist Hospital /ID# 269580, Omaha, Nebraska

The Center Of Hope /ID# 269528, Reno, Nevada

Dartmouth-Hitchcock Medical Center - 1 Medical Center Drive /ID# 269576, Lebanon, New Hampshire

John Theurer Cancer Center /ID# 269109, Hackensack, New Jersey

The Valley Hospital /ID# 269548, Paramus, New Jersey

Holy Name Medical Center /ID# 269543, Teaneck, New Jersey

New York Oncology Hematology - Albany Cancer Center /ID# 269565, Albany, New York

Women'S Cancer Care Associates /ID# 269553, Albany, New York

Northwell Health Center for Advanced Medicine /ID# 269108, Lake Success, New York

NYU Laura and Isaac Perlmutter Cancer Center /ID# 269556, New York, New York

Icahn School of Medicine at Mount Sinai /ID# 269529, New York, New York

University of North Carolina at Chapel Hill /ID# 269563, Chapel Hill, North Carolina

Duke Cancer Institute /ID# 269557, Durham, North Carolina

University of Cincinnati /ID# 269578, Cincinnati, Ohio

The Ohio State University Comprehensive Cancer Center /ID# 269105, Columbus, Ohio

Kettering Medical Center /ID# 269585, Kettering, Ohio

Ou Health - Stephenson Cancer Center /ID# 269525, Oklahoma City, Oklahoma

Oklahoma Cancer Specialists and Research Institute /ID# 269527, Tulsa, Oklahoma

Willamette Valley Cancer Institute and Research Center /ID# 269988, Eugene, Oregon

Compass Oncology - Rose Quarter /ID# 270131, Portland, Oregon

Oregon Health and Science University /ID# 269581, Portland, Oregon

Magee-Womens Hospital of UPMC /ID# 269659, Pittsburgh, Pennsylvania

Allegheny Health Network West Penn Hospital /ID# 269551, Pittsburgh, Pennsylvania

Asplundh Cancer Pavilion /ID# 269574, Willow Grove, Pennsylvania

Sanford Cancer Center /ID# 269535, Sioux Falls, South Dakota

West Cancer Center and Research Institute - Germantown /ID# 269569, Germantown, Tennessee

Texas Oncology - Austin Central /ID# 269531, Austin, Texas

Texas Oncology - Bedford /ID# 269571, Bedford, Texas

Texas Oncology - Methodist Dallas Cancer Center /ID# 269554, Dallas, Texas

Texas Oncology - Fort Worth Cancer Center /ID# 269532, Fort Worth, Texas

Texas Oncology, P. A. /ID# 269549, San Antonio, Texas

University of Virginia Health System /ID# 269545, Charlottesville, Virginia

Virginia Oncology Associates - Norfolk (Lake Wright) /ID# 269533, Norfolk, Virginia

Vcu Health Adult Outpatient Pavillion /ID# 269570, Richmond, Virginia

Swedish Cancer Institute /ID# 269538, Seattle, Washington

Sanatorio De La Mujer /ID# 269352, Rosario, Santa Fe

Hospital Italiano de Buenos Aires /ID# 269356, Buenos Aires, Not set

Sociedad de Beneficiencia Hospital Italiano /ID# 269090, Cordoba, Not set

Isis Centro Especializado De Luce /ID# 269353, Santa Fe, Not set

Westmead Hospital /ID# 269362, Westmead, New South Wales

Gold Coast University Hospital /ID# 269365, Southport, Queensland

Ballarat Base Hospital /ID# 269364, Ballarat, Victoria

Monash Health - Monash Medical Centre /ID# 269360, Clayton, Victoria

Cabrini Hospital - Malvern /ID# 269359, Malvern, Victoria

Peter MacCallum Cancer Centre /ID# 269361, Melbourne, Victoria

Epworth Hospital /ID# 269363, Richmond, Victoria

St. John Of God Subiaco Hospital /ID# 269358, Subiaco, Western Australia

Imelda Ziekenhuis /ID# 269369, Bonheiden, Antwerpen

Cliniques Universitaires UCL Saint-Luc /ID# 269368, Bruxelles, Bruxelles-Capitale

Grand Hôpital De Charleroi - Notre Dame /ID# 269367, Charleroi, Hainaut

AZ Sint-Lucas /ID# 269366, Gent, Oost-Vlaanderen

Universitair Ziekenhuis Leuven /ID# 269370, Leuven, Vlaams-Brabant

AZ-Delta /ID# 269091, Roeselare, West-Vlaanderen

UCL Namur University Hospital, Site Sainte-Elisabeth /ID# 269371, Namur, Not set

Complex Oncology Center - Shumen /ID# 269372, Shumen, Not set

Comprehensive Cancer Center /ID# 269373, Vratsa, Not set

Arthur J. E. Child Comprehensive Cancer Centre /ID# 269388, Calgary, Alberta

Cross Cancer Institute /ID# 269392, Edmonton, Alberta

Bc Cancer Agency - Fraser Valley Centre /ID# 269398, Surrey, British Columbia

BC Cancer - Vancouver /ID# 269394, Vancouver, British Columbia

Juravinski Cancer Centre - Hamilton Health Sciences /ID# 269396, Hamilton, Ontario

Kingston General Hospital /ID# 269397, Kingston, Ontario

The Ottawa Hospital - General Campus /ID# 269391, Ottawa, Ontario

Princess Margaret Cancer Centre /ID# 269390, Toronto, Ontario

Universite de Montreal - Hopital Maisonneuve-Rosemont /ID# 269395, Montreal, Quebec

CHUM - Centre hospitalier de l'Universite de Montréal /ID# 269387, Montreal, Quebec

McGill University Health Centre /ID# 269389, Montreal, Quebec

CIUSSS Estrie - Sherbrooke University Hospital Center /ID# 269393, Sherbrooke, Quebec

The first affiliated hospital of bengbu medical college, Bengbu, Anhui

Capital Medical University (Cmu), Beijing, Beijing

Beijing Cancer Hospital, Beijing, Beijing

Fujian Province Cancer Hospital, Fuzhou, Fujian

The First Affiliated Hospital, Sun-Yat Sen University, Guangzhou, Guangdong

Sun Yat-Sen University (Sysu) - Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong

Affiliated Cancer Hospital of Guangxi Medical University, Nanning, Guangxi

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang

Henan Cancer Hospital, Zhengzhou, Henan

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Hubei Cancer Hospital, Wuhan, Hubei

Hunan Province Cancer Hospital, Changsha, Hunan

The First Bethune Hospital Of Jilin University, Changchun, Jilin

Liaoning Cancer Hospital & Institute, Shenyang, Liaoning

The First Affiliated Hospital of Xi'an Jiaotong University, Xian, Shaanxi

Qilu Hospital Of Shandong University, Jinan, Shandong

Shandong Cancer Hospital, Jinan, Shandong

LinYi Cancer Hospital, Linyi, Shandong

Fudan University Cancer Hospital, Shanghai, Shanghai

Shanxi Cancer Hospital, Taiyuan, Shanxi

West China Second University Hospital, Sichuan University, Chengdu, Sichuan

Tianjin Cancer Hospital, Tianjin, Tianjin

Cancer Hospital Affliated to Xinjiang Medical University, Urumqi, Xinjiang

Yunnan Province Cancer Hospital, Kunming, Yunnan

The Affiliated Women's Hospital Of Zhejiang University, Hangzhou, Zhejiang

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Fakultní Nemocnice Brno - Jihlavská /ID# 269401, Brno, Brno-mesto

General University Hospital in Prague, Charles University /ID# 269402, Prague, Ceske Budejovice

Nemocnice Novy Jicin /ID# 269400, Nový Jičín, Novy Jicin

Fakultní nemocnice Ostrava /ID# 269403, Ostrava, Ostrava-mesto

Hôpital La Timone /ID# 269421, Marseille, Bouches-du-Rhone

Chu Dijon /Id# 269417, Dijon, Bourgogne-Franche-Comte

CHU Brest /ID# 269422, Brest, Finistere

Centre Leon Berard /ID# 269418, Lyon CEDEX 08, Rhone

Institut Curie /ID# 269420, Paris, Not set

Institut de cancérologie Strasbourg Europe (ICANS) /ID# 269419, Strasbourg, Not set

Klinikum Esslingen /ID# 269435, Esslingen am Neckar, Baden-Wuerttemberg

Universitaetsklinikum Erlangen /ID# 269439, Erlangen, Bayern

Universitaetsklinikum Bonn /ID# 269434, Bonn, Nordrhein-Westfalen

Klinikum Dortmund Klinikzentrum Mitte /ID# 269441, Dortmund, Nordrhein-Westfalen

Universitaetsklinikum Carl Gustav Carus Dresden /ID# 269433, Dresden, Sachsen

Universitätsklinikum Gießen /ID# 269432, Giessen, Not set

Krankenhaus Jerusalem /ID# 269430, Hamburg, Not set

St. Luke's Hospital S.A. /ID# 269445, Panorama, Thessaloniki

General Hospital of Athens Alexandra /ID# 269444, Athens, Not set

Hygeia Hospital /ID# 270132, Athens, Not set

IASO Hospital /ID# 269443, Marousi, Not set

St James Hospital /ID# 269446, Dublin 8, Dublin

Bon Secours Cork Hospital /ID# 269449, Cork, Not set

Cork University Hospital /ID# 269451, Cork, Not set

Beaumont Hospital /ID# 269452, Dublin, Not set

University Hospital Galway /ID# 269447, Galway, Not set

Sligo General Hospital /ID# 269448, Sligo, Not set

Waterford Regional Hospital /ID# 269450, Waterford, Not set

The Lady Davis Carmel Medical Center /ID# 269453, Haifa, H_efa

Edith Wolfson Medical Center /ID# 269461, Holon, HaMerkaz

Meir Medical Center /ID# 269454, Kfar Saba, HaMerkaz

Rabin Medical Center /ID# 269456, Petah Tikva, HaMerkaz

Kaplan Medical Center /ID# 269457, Rekhovot, HaMerkaz

The Chaim Sheba Medical Center /ID# 269094, Ramat Gan, Tel-Aviv

Tel Aviv Sourasky Medical Center /ID# 269455, Tel Aviv, Tel-Aviv

Shaare Zedek Medical Center /ID# 269459, Jerusalem, Not set

Hadassah Medical Center-Hebrew University /ID# 269458, Jerusalem, Not set

ZIV Medical Center /ID# 269460, Safed, Not set

Azienda Ospedaliero Universitaria Careggi /ID# 269465, Florence, Firenze

Ente Ospedaliero Ospedali Galliera /ID# 269472, Genoa, Genova

Ospedale San Martino /ID# 269469, Genoa, Genova

IRCCS Istituto Clinico Humanitas /ID# 269473, Rozzano, Lombardia

IRCCS Ospedale San Raffaele /ID# 269475, Milan, Milano

Istituto Nazionale Dei Tumori /ID# 269477, Milan, Milano

Istituto Nazionale Tumori Irccs Fondazione G. Pascale /ID# 269097, Naples, Napoli

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST - IRCCS /ID# 269474, Meldola, Reggio Emilia

Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 269470, Rome, Roma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 269096, Rome, Roma

Ospedale di Mirano - Azienda ULSS 3 /ID# 269462, Mirano, Venezia

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 269476, Bologna, Not set

Ospedale Cannizzaro /ID# 269478, Catania, Not set

Alessandro Manzoni Hospital /ID# 269467, Lecco, Not set

Azienda USL Toscana Nord Ovest - Ospedale San Luca /ID# 269095, Lucca, Not set

Azienda Ospedaliero Universitaria Di Parma /ID# 269466, Parma, Not set

Fondazione IRCCS Policlinico San Matteo /ID# 269463, Pavia, Not set

AUSL Piacenza-Ospedale Guglielmo da Saliceto /ID# 269468, Piacenza, Not set

New Hospital of Prato - S. Stefano /ID# 269464, Prato, Not set

AUSL di Reggio Emilia - Arcispedale Santa Maria Nuova /ID# 269471, Reggio Emilia, Not set

Aichi Cancer Center /ID# 274332, Nagoya-shi, Aichi

Chiba University Hospital /ID# 274371, Chiba-shi, Chiba

National Hospital Organization Shikoku Cancer Center /ID# 276078, Matsuyama, Ehime

Kurume University Hospital /ID# 274337, Kurume-shi, Fukuoka

Hokkaido University Hospital /ID# 274331, Sapporo-shi, Hokkaido

Sapporo Medical University Hospital /ID# 274330, Sapporo, Hokkaido

Hyogo Cancer Center /ID# 274323, Akashi-shi, Hyogo

Iwate Medical University Hospital - Yahabacho /ID# 274635, Yahaba, Iwate

Tokai University Hospital /ID# 274336, Isehara, Kanagawa

Tohoku University Hospital /ID# 274327, Sendai-shi, Miyagi

Niigata University Medical & Dental Hospital /ID# 274329, Niigata-shi, Niigata

Okayama University Hospital /ID# 274324, Okayama-shi, Okayama

Saitama Medical University International Medical Center /ID# 274953, Hidaka, Saitama

Shizuoka Cancer Center /ID# 274325, Sunto-gun, Shizuoka

National Cancer Center Hospital /ID# 274321, Chuo-Ku, Tokyo

The Cancer Institute Hospital Of JFCR /ID# 274326, Koto-ku, Tokyo

The Jikei University Hospital /ID# 276160, Minato-ku, Tokyo

Keio University Hospital /ID# 276159, Shinjuku-ku, Tokyo

National Cancer Center /ID# 269481, Goyang-si, Gyeonggido

Seoul National University Bundang Hospital /ID# 269482, Seongnam-si, Gyeonggido

CHA Bundang Medical Center /ID# 269489, Seongnam, Gyeonggido

Keimyung University Dongsan Hospital /ID# 269488, Daegu, Gyeongsangbugdo

Korea University Anam Hospital /ID# 269486, Seoul, Seoul Teugbyeolsi

Seoul National University Hospital /ID# 269479, Seoul, Seoul Teugbyeolsi

Yonsei University Health System Severance Hospital /ID# 269483, Seoul, Seoul Teugbyeolsi

Asan Medical Center /ID# 269480, Seoul, Seoul Teugbyeolsi

Gangnam Severance Hospital /ID# 269484, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 269487, Seoul, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 269485, Seoul, Seoul Teugbyeolsi

Korea University Guro Hospital /ID# 269490, Seoul, Seoul Teugbyeolsi

The Medical City /ID# 269493, Pasig, National Capital Region

East Avenue Medical Center /ID# 269099, Quezon City, National Capital Region

Cardinal Santos Medical Center /ID# 269100, San Juan City, National Capital Region

Mazowiecki Szpital Wojewodzki im. Sw. Jana Pawla II w Siedlcach Sp. z o.o. /ID# 269500, Siedlce, Mazowieckie

Szpitale Pomorskie Sp. z o.o. /ID# 269495, Gdynia, Pomorskie

Complejo Hospitalario Universitario A Coruña /ID# 269414, A Coruña, A Coruna

Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 269409, L'Hospitalet de Llobregat, Barcelona

Clinica Universidad de Navarra - Pamplona /ID# 269410, Pamplona, Navarra

Hospital Universitari Vall d'Hebron /ID# 269406, Barcelona, Not set

Hospital Clinic de Barcelona /ID# 269408, Barcelona, Not set

Hospital Universitari De Girona Doctor Josep Trueta /ID# 269411, Girona, Not set

CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 269405, Madrid, Not set

Hospital Universitario La Paz /ID# 269407, Madrid, Not set

Hospital Clínico Universitario de Valencia /ID# 269412, Valencia, Not set

Hacettepe University Faculty of Medicine /ID# 269521, Ankara, Not set

Cheltenham General Hospital /ID# 269427, Cheltenham, Gloucestershire

Guy's Hospital /ID# 269426, London, Greater London

The Royal Marsden - Chelsea /ID# 269102, London, Greater London

Mount Vernon Hospital /ID# 269423, Northwood, Greater London

University Hospital Southampton /ID# 269425, Southampton, Hampshire

The Royal Marsden - Sutton /ID# 269103, Sutton, Surrey

The Christie /ID# 269428, Manchester, Not set

Singleton Hospital /ID# 269424, Swansea, Not set

Conditions: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

Learn More ›

A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.

NCT05497778

Recruiting

To learn if adding a new medication, IM156, to treatment with gemcitabine and nab-paclitaxel is safe and tolerable. The ability of this combination to improve the success of this treatment for these patients will also be studied.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/21/2025

Locations: MD Anderson Cancer Center, Houston, Texas

Conditions: Pancreas Cancer

Learn More ›

Cryoablation vs Lumpectomy in T1 Breast Cancers

NCT05505643

Recruiting

This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a method of killing a tumor by freezing it. The standard approach for patients with this kind of cancer is a lumpectomy. This study will review the safety of the cryoablation procedure initially, followed by comparing cryoablation to lumpectomy in order to see if the cryoablation results in better disease control, complication rates, and quality of life.

Gender:

FEMALE

Ages:

50 years and above

Trial Updated:

07/21/2025

Locations: Washington University School of Medicine, Saint Louis, Missouri

Conditions: Breast Cancer, Breast Neoplasm

Learn More ›

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

NCT05548296

Recruiting

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial cancer.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/21/2025

Locations: University of South Alabama Mitchell Cancer Institute, Mobile, Alabama +68 locations

University of South Alabama Mitchell Cancer Institute, Mobile, Alabama

Alaska Women's Cancer Center, Anchorage, Alaska

HonorHealth, Phoenix, Arizona

Arizona Oncology Associate, PC- HOPE, Tucson, Arizona

University of Arkansas for Medical Sciences, Little Rock, Arkansas

City of Hope National Medical Center, Duarte, California

UC San Diego Moores Cancer Center, La Jolla, California

USC/Norris Comprehensive Cancer Center, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Hoag Cancer Center, Newport Beach, California

UC Irvine Health, Orange, California

Stanford Cancer Center, Palo Alto, California

University of California, Davis Comprehensive Cancer Center, Sacramento, California

University of California Los Angeles (UCLA), Santa Monica, California

University of Colorado, Aurora, Colorado

Yale Cancer Center, New Haven, Connecticut

Florida Gynecologic Oncology/Regional Cancer Center, Fort Myers, Florida

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Emory University, Atlanta, Georgia

Northeast Georgia Medical Center, Gainesville, Georgia

Northwestern Medicine, Chicago, Illinois

University of Illinois Cancer Center, Chicago, Illinois

University of Chicago Medicine, Chicago, Illinois

Carle Cancer Center, Urbana, Illinois

Ascension St. Vicent Hospital, Inc., Indianapolis, Indiana

University of Iowa, Iowa City, Iowa

LSU Health Sciences, New Orleans, Louisiana

Trials365, LLC, Shreveport, Louisiana

American Oncology Partners of Maryland PA, Bethesda, Maryland

National Institutes of Health, Clinical Center, Bethesda, Maryland

Holy Cross Hospital, Silver Spring, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

University of Massachusetts Chan Medical School, Worcester, Massachusetts

Karmanos Cancer Institute, Detroit, Michigan

HCA Midwest, Kansas City, Missouri

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey

Rutgers Cancer Institute of NJ, New Brunswick, New Jersey

Laura & Isaac Perlmutter Cancer Center, New York, New York

New York Presbyterian Hospital-Columbia University Medical Center, New York, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

Mount Sinai Health System, New York, New York

University of Rochester Medical Center, Rochester, New York

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

FirstHealth of the Carolinas, Pinehurst, North Carolina

Gabrail Cancer Center, Canton, Ohio

Miami Valley Hospital South, Centerville, Ohio

University of Cincinnati Cancer Center, Cincinnati, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Ohio State University, Hilliard, Ohio

Stephenson Cancer Center at OU Health, Oklahoma City, Oklahoma

Oncology Associates of Oregon, Eugene, Oregon

Oregon Health & Sciences University, Portland, Oregon

Fox Chase Cancer Center, Philadelphia, Pennsylvania

West Penn Hospital, Pittsburgh, Pennsylvania

Women & Infants Hospital, Providence, Rhode Island

Sanford Health, Sioux Falls, South Dakota

Texas Oncology-Dallas Presbyterian Hospital, Dallas, Texas

University of Texas Southwestern Medical Center, Dallas, Texas

Texas Oncology, Fort Worth, Texas

University of Texas, MD Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah

University of Virginia Health System, Charlottesville, Virginia

Virginia Commonwealth University, Richmond, Virginia

Swedish Cancer Center, Seattle, Washington

Fred Hutchinson Cancer Center, Seattle, Washington

Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington

Summit Cancer Center, Spokane, Washington

Northwest Cancer Specialists, P.C., Vancouver, Washington

Froedtert and Medical College of Wisconsin, Milwaukee, Wisconsin

Conditions: Endometrial Adenocarcinoma

Learn More ›

Pembro With Radiation With or Without Olaparib

NCT05568550

Recruiting

This trial will evaluate whether the immune-sensitizing effects of immunotherapy (Pembrolizumab) and radiation with or without a PARP-inhibitor (Olaparib) will increase the effects of immunotherapy in men with high-risk localized prostate cancer.

Gender:

MALE

Ages:

18 years and above

Trial Updated:

07/21/2025

Locations: University of Kentucky, Lexington, Kentucky +1 locations

Conditions: Prostate Cancer

Learn More ›